Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue Is DoorDash DASH stock fairly valued DoorDash Posts 197 EPS Miss Trails Analyst Estimates Dow Inc DOW PostQ1 2026 Earnings Pullback Amid Elevated Valuation and Macro Volatility